Ellutia Chromatography Solutions Open New Facility
Ellutia Chromatography Solutions has opened a new state‑of‑the-art facility in Ely, Cambridgeshire, UK, consolidating Ellutia’s offices, laboratories, production, and warehouse on one 15,000 sq. ft. site.
Ellutia Chromatography Solutions has opened a new stateâofâthe-art facility in Ely, Cambridgeshire, UK, consolidating Ellutia’s offices, laboratories, production, and warehouse on one 15,000 sq. ft. site.
The site gives Ellutia room for its planned growth and the company expects to increase its staff levels by 40% over the next two years.
“Ellutia’s long-term strategy focuses on evolving and enhancing our product offerings, continually improving service to our customers, and strengthening the network of R&D companies in the Cambridge area,” said Philip James, Managing Director at Ellutia.
Formerly Cambridge Scientific Instruments Ltd., Ellutia decided to stay close to its spiritual home basing its new facility just outside of the city of Cambridge.
“A key consideration for us when choosing this location was our staff,” explained James. “By being based outside the city of Cambridge, our employees enjoy the travel benefits and lower cost of living Ely offers. But we are still in close proximity to Cambridge and London, where much scientific innovation takes place with the help of our instruments.”
For more information please visit: www.ellutia.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
